Cargando…

Dephosphorylation Passivates the Seeding Activity of Oligomeric Tau Derived From Alzheimer’s Brain

Accumulation of intracellular neurofibrillary tangles (NFTs), which are constituted of abnormally phosphorylated tau, is one of the neuropathological hallmarks of Alzheimer’s disease (AD). The oligomeric aggregates of tau in AD brain (AD O-tau) are believed to trigger NFT spreading by seeding normal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Ruozhen, Li, Longfei, Shi, Ruirui, Zhou, Yan, Jin, Nana, Gu, Jianlan, Tung, Yunn Chyn, Liu, Fei, Chu, Dandan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155256/ https://www.ncbi.nlm.nih.gov/pubmed/34054426 http://dx.doi.org/10.3389/fnmol.2021.631833

Ejemplares similares

Two simple assays for assessing the seeding activity of proteopathic tau
por: Liu, Fei, et al.
Publicado: (2023)

Alzheimer’s disease brain contains tau fractions with differential prion-like activities
por: Li, Longfei, et al.
Publicado: (2021)

Tau seeding activity in various regions of down syndrome brain assessed by two novel assays
por: Jin, Nana, et al.
Publicado: (2022)

Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
por: Miao, Jin, et al.
Publicado: (2019)

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice
por: Dai, Chun-ling, et al.
Publicado: (2018)

Tau antibody 77G7 targeting microtubule binding domain suppresses proteopathic tau to seed tau aggregation
por: Li, Longfei, et al.
Publicado: (2022)

Tau passive immunization inhibits not only tau but also Aβ pathology
por: Dai, Chun-ling, et al.
Publicado: (2017)

Formation and Propagation of Tau Oligomeric Seeds
por: Gerson, Julia E., et al.
Publicado: (2013)

Involvement of Activation of Asparaginyl Endopeptidase in Tau Hyperphosphorylation in Repetitive Mild Traumatic Brain Injury
por: Hu, Wen, et al.
Publicado: (2018)

Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain
por: DeVos, Sarah L., et al.
Publicado: (2018)

Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
por: Zhou, Yan, et al.
Publicado: (2018)

Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species
por: Chen, Xu-Qiao, et al.
Publicado: (2019)

Characterization of tau oligomeric seeds in progressive supranuclear palsy
por: Gerson, Julia E, et al.
Publicado: (2014)

Sirt1 enhances tau exon 10 inclusion and improves spatial memory of Htau mice
por: Qian, Shuo, et al.
Publicado: (2018)

In vivo rate-determining steps of tau seed accumulation in Alzheimer’s disease
por: Meisl, Georg, et al.
Publicado: (2021)

Up-regulation of casein kinase 1ε is involved in tau pathogenesis in Alzheimer’s disease
por: Chen, Caoyi, et al.
Publicado: (2017)

Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
por: Mate De Gerando, Anastasie, et al.
Publicado: (2023)

Passive Immunization With a Novel Monoclonal Anti-PrP Antibody TW1 in an Alzheimer’s Mouse Model With Tau Pathology
por: Boutajangout, Allal, et al.
Publicado: (2021)

Prenatal to early postnatal neurotrophic treatment prevents Alzheimer-like behavior and pathology in mice
por: Wei, Wei, et al.
Publicado: (2020)

Phosphorylation and Dephosphorylation of Tau Protein During Synthetic Torpor
por: Luppi, Marco, et al.
Publicado: (2019)

Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction
por: Wei, Wei, et al.
Publicado: (2021)

Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies
por: Ferrer, Isidro, et al.
Publicado: (2019)

Excess Folic Acid Supplementation Before and During Pregnancy and Lactation Activates Fos Gene Expression and Alters Behaviors in Male Mouse Offspring
por: Chu, Dandan, et al.
Publicado: (2019)

Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
por: Qin, Wei, et al.
Publicado: (2022)

Seeding Activity-Based Detection Uncovers the Different Release Mechanisms of Seed-Competent Tau Versus Inert Tau via Lysosomal Exocytosis
por: Tanaka, Yuki, et al.
Publicado: (2019)

A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies
por: Zheng, Jie, et al.
Publicado: (2021)

Passive immunotherapies targeting Aβ and tau in Alzheimer's disease
por: Plotkin, Steven S., et al.
Publicado: (2020)

Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in physiology and pathology
por: DeFelipe, Javier
Publicado: (2016)

PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer’s Disease
por: Luna-Viramontes, Nabil Itzi, et al.
Publicado: (2020)

Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease
por: Marksteiner, Josef, et al.
Publicado: (2022)

In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ protein
por: McIntee, Farron L., et al.
Publicado: (2016)

The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease
por: Cheng, Ying, et al.
Publicado: (2018)

Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
por: Ando, Kunie, et al.
Publicado: (2021)

Implication of tau propagation on neurodegeneration in Alzheimer’s disease
por: Lamontagne-Kam, Daniel, et al.
Publicado: (2023)

Stargazin Dephosphorylation Mediates Homeostatic Synaptic Downscaling of Excitatory Synapses
por: Louros, Susana R., et al.
Publicado: (2018)

Tau kinetics in Alzheimer's disease
por: Hier, Daniel B., et al.
Publicado: (2022)

Quantitative Methods for the Detection of Tau Seeding Activity in Human Biofluids
por: Lathuiliere, Aurelien, et al.
Publicado: (2021)

Tau Ubiquitination in Alzheimer's Disease
por: Li, Longfei, et al.
Publicado: (2022)

Dysregulation of Protein Phosphorylation/Dephosphorylation in Alzheimer's Disease: A Therapeutic Target
por: Gong, Cheng-Xin, et al.
Publicado: (2006)

Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
por: Guerrero-Muñoz, Marcos J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hp2daftl73jek950gs3e33fb0g